nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Nucleoside Analog—Azathioprine—multiple sclerosis	0.455	1	CiPCiCtD
Lamivudine—Decitabine—Cladribine—multiple sclerosis	0.169	1	CrCrCtD
Lamivudine—DCK—Cladribine—multiple sclerosis	0.0762	0.312	CbGbCtD
Lamivudine—SLC22A2—Cladribine—multiple sclerosis	0.022	0.09	CbGbCtD
Lamivudine—SLC22A1—Cladribine—multiple sclerosis	0.0191	0.0782	CbGbCtD
Lamivudine—ABCC1—Mitoxantrone—multiple sclerosis	0.0177	0.0725	CbGbCtD
Lamivudine—ABCG2—Cladribine—multiple sclerosis	0.0162	0.0665	CbGbCtD
Lamivudine—ABCC3—Methotrexate—multiple sclerosis	0.012	0.0492	CbGbCtD
Lamivudine—ABCG2—Mitoxantrone—multiple sclerosis	0.0118	0.0485	CbGbCtD
Lamivudine—ABCC4—Methotrexate—multiple sclerosis	0.00917	0.0376	CbGbCtD
Lamivudine—ABCC1—Methotrexate—multiple sclerosis	0.00737	0.0302	CbGbCtD
Lamivudine—ABCC2—Dexamethasone—multiple sclerosis	0.00679	0.0278	CbGbCtD
Lamivudine—ABCG2—Dexamethasone—multiple sclerosis	0.00614	0.0251	CbGbCtD
Lamivudine—ABCB1—Methylprednisolone—multiple sclerosis	0.00585	0.024	CbGbCtD
Lamivudine—ABCC2—Methotrexate—multiple sclerosis	0.00546	0.0223	CbGbCtD
Lamivudine—ABCG2—Methotrexate—multiple sclerosis	0.00493	0.0202	CbGbCtD
Lamivudine—ABCB1—Mitoxantrone—multiple sclerosis	0.00427	0.0175	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—multiple sclerosis	0.00399	0.0164	CbGbCtD
Lamivudine—ABCB1—Betamethasone—multiple sclerosis	0.0038	0.0156	CbGbCtD
Lamivudine—ABCB1—Prednisolone—multiple sclerosis	0.00375	0.0154	CbGbCtD
Lamivudine—ABCB1—Prednisone—multiple sclerosis	0.00354	0.0145	CbGbCtD
Lamivudine—NME2—pineal body—multiple sclerosis	0.00237	0.0913	CbGeAlD
Lamivudine—ABCB1—Dexamethasone—multiple sclerosis	0.00221	0.00907	CbGbCtD
Lamivudine—ABCB1—Methotrexate—multiple sclerosis	0.00178	0.00728	CbGbCtD
Lamivudine—PGK1—brainstem—multiple sclerosis	0.00148	0.057	CbGeAlD
Lamivudine—Gemcitabine—RRM1—multiple sclerosis	0.00132	1	CrCbGaD
Lamivudine—PCYT2—nervous system—multiple sclerosis	0.000903	0.0348	CbGeAlD
Lamivudine—PCYT2—central nervous system—multiple sclerosis	0.00087	0.0335	CbGeAlD
Lamivudine—PGK1—nervous system—multiple sclerosis	0.000776	0.0299	CbGeAlD
Lamivudine—CMPK1—brainstem—multiple sclerosis	0.000756	0.0291	CbGeAlD
Lamivudine—PGK1—central nervous system—multiple sclerosis	0.000747	0.0288	CbGeAlD
Lamivudine—NME2—brainstem—multiple sclerosis	0.000739	0.0285	CbGeAlD
Lamivudine—PGK1—cerebellum—multiple sclerosis	0.00073	0.0281	CbGeAlD
Lamivudine—NME2—retina—multiple sclerosis	0.000713	0.0275	CbGeAlD
Lamivudine—PCYT2—brain—multiple sclerosis	0.00069	0.0266	CbGeAlD
Lamivudine—NT5C—nervous system—multiple sclerosis	0.000655	0.0252	CbGeAlD
Lamivudine—NT5C—central nervous system—multiple sclerosis	0.000631	0.0243	CbGeAlD
Lamivudine—NT5C—cerebellum—multiple sclerosis	0.000617	0.0237	CbGeAlD
Lamivudine—PCYT1A—nervous system—multiple sclerosis	0.000615	0.0237	CbGeAlD
Lamivudine—PGK1—brain—multiple sclerosis	0.000593	0.0228	CbGeAlD
Lamivudine—PCYT1A—central nervous system—multiple sclerosis	0.000592	0.0228	CbGeAlD
Lamivudine—NT5C—brain—multiple sclerosis	0.000501	0.0193	CbGeAlD
Lamivudine—CMPK1—midbrain—multiple sclerosis	0.000482	0.0186	CbGeAlD
Lamivudine—CMPK1—spinal cord—multiple sclerosis	0.00047	0.0181	CbGeAlD
Lamivudine—PCYT1A—brain—multiple sclerosis	0.00047	0.0181	CbGeAlD
Lamivudine—NME1—nervous system—multiple sclerosis	0.000411	0.0158	CbGeAlD
Lamivudine—CMPK1—nervous system—multiple sclerosis	0.000396	0.0153	CbGeAlD
Lamivudine—NME1—central nervous system—multiple sclerosis	0.000396	0.0152	CbGeAlD
Lamivudine—NME2—nervous system—multiple sclerosis	0.000387	0.0149	CbGeAlD
Lamivudine—NME1—cerebellum—multiple sclerosis	0.000387	0.0149	CbGeAlD
Lamivudine—CMPK1—central nervous system—multiple sclerosis	0.000381	0.0147	CbGeAlD
Lamivudine—CMPK1—cerebellum—multiple sclerosis	0.000373	0.0144	CbGeAlD
Lamivudine—NME2—central nervous system—multiple sclerosis	0.000373	0.0144	CbGeAlD
Lamivudine—NME2—cerebellum—multiple sclerosis	0.000364	0.014	CbGeAlD
Lamivudine—DCK—retina—multiple sclerosis	0.000363	0.014	CbGeAlD
Lamivudine—NME1—brain—multiple sclerosis	0.000314	0.0121	CbGeAlD
Lamivudine—CMPK1—brain—multiple sclerosis	0.000303	0.0117	CbGeAlD
Lamivudine—NME2—brain—multiple sclerosis	0.000296	0.0114	CbGeAlD
Lamivudine—DCK—medulla oblongata—multiple sclerosis	0.000263	0.0101	CbGeAlD
Lamivudine—DCK—midbrain—multiple sclerosis	0.00024	0.00924	CbGeAlD
Lamivudine—DCK—spinal cord—multiple sclerosis	0.000234	0.00902	CbGeAlD
Lamivudine—SLC22A6—brain—multiple sclerosis	0.000198	0.00761	CbGeAlD
Lamivudine—DCK—nervous system—multiple sclerosis	0.000197	0.0076	CbGeAlD
Lamivudine—DCK—central nervous system—multiple sclerosis	0.00019	0.00731	CbGeAlD
Lamivudine—ABCC3—nervous system—multiple sclerosis	0.000189	0.00727	CbGeAlD
Lamivudine—DCK—cerebellum—multiple sclerosis	0.000186	0.00715	CbGeAlD
Lamivudine—ABCC3—central nervous system—multiple sclerosis	0.000182	0.007	CbGeAlD
Lamivudine—SLC22A1—nervous system—multiple sclerosis	0.000168	0.00648	CbGeAlD
Lamivudine—SLC22A1—central nervous system—multiple sclerosis	0.000162	0.00624	CbGeAlD
Lamivudine—SLC22A3—nervous system—multiple sclerosis	0.000161	0.00619	CbGeAlD
Lamivudine—ABCC4—nervous system—multiple sclerosis	0.000156	0.006	CbGeAlD
Lamivudine—SLC22A3—central nervous system—multiple sclerosis	0.000155	0.00596	CbGeAlD
Lamivudine—DCK—brain—multiple sclerosis	0.000151	0.00581	CbGeAlD
Lamivudine—ABCC4—central nervous system—multiple sclerosis	0.00015	0.00578	CbGeAlD
Lamivudine—ABCG2—medulla oblongata—multiple sclerosis	0.000146	0.00564	CbGeAlD
Lamivudine—ABCC3—brain—multiple sclerosis	0.000144	0.00556	CbGeAlD
Lamivudine—ABCG2—midbrain—multiple sclerosis	0.000134	0.00516	CbGeAlD
Lamivudine—ABCG2—spinal cord—multiple sclerosis	0.000131	0.00503	CbGeAlD
Lamivudine—SLC22A1—brain—multiple sclerosis	0.000129	0.00495	CbGeAlD
Lamivudine—ABCC1—cerebellum—multiple sclerosis	0.000125	0.00482	CbGeAlD
Lamivudine—SLC22A3—brain—multiple sclerosis	0.000123	0.00473	CbGeAlD
Lamivudine—ABCC4—brain—multiple sclerosis	0.000119	0.00459	CbGeAlD
Lamivudine—NME1—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000111	0.0876	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000109	0.0862	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000109	0.0862	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000107	0.0843	CbGdCrCtD
Lamivudine—ABCG2—cerebellum—multiple sclerosis	0.000104	0.00399	CbGeAlD
Lamivudine—ABCC1—brain—multiple sclerosis	0.000102	0.00391	CbGeAlD
Lamivudine—ABCB1—retina—multiple sclerosis	9.99e-05	0.00385	CbGeAlD
Lamivudine—ABCG2—brain—multiple sclerosis	8.41e-05	0.00324	CbGeAlD
Lamivudine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	7.36e-05	0.058	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	7.25e-05	0.0571	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	7.25e-05	0.0571	CbGdCrCtD
Lamivudine—ABCB1—medulla oblongata—multiple sclerosis	7.22e-05	0.00278	CbGeAlD
Lamivudine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	7.15e-05	0.0563	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	7.08e-05	0.0558	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	7.03e-05	0.0555	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Betamethasone—multiple sclerosis	7.03e-05	0.0555	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	6.87e-05	0.0542	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisone—multiple sclerosis	6.72e-05	0.053	CbGdCrCtD
Lamivudine—ABCB1—midbrain—multiple sclerosis	6.6e-05	0.00254	CbGeAlD
Lamivudine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	6.56e-05	0.0517	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisone—multiple sclerosis	6.52e-05	0.0514	CbGdCrCtD
Lamivudine—ABCB1—spinal cord—multiple sclerosis	6.44e-05	0.00248	CbGeAlD
Lamivudine—DCK—Diflorasone—Prednisolone—multiple sclerosis	6.37e-05	0.0502	CbGdCrCtD
Lamivudine—ABCB1—nervous system—multiple sclerosis	5.43e-05	0.00209	CbGeAlD
Lamivudine—ABCB1—central nervous system—multiple sclerosis	5.23e-05	0.00201	CbGeAlD
Lamivudine—ABCB1—cerebellum—multiple sclerosis	5.11e-05	0.00197	CbGeAlD
Lamivudine—Vertigo—Betamethasone—multiple sclerosis	4.23e-05	0.000605	CcSEcCtD
Lamivudine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.22e-05	0.000604	CcSEcCtD
Lamivudine—Syncope—Betamethasone—multiple sclerosis	4.22e-05	0.000604	CcSEcCtD
Lamivudine—Syncope—Dexamethasone—multiple sclerosis	4.22e-05	0.000604	CcSEcCtD
Lamivudine—Infection—Triamcinolone—multiple sclerosis	4.2e-05	0.000602	CcSEcCtD
Lamivudine—Sweating—Methotrexate—multiple sclerosis	4.2e-05	0.000601	CcSEcCtD
Lamivudine—Infection—Methylprednisolone—multiple sclerosis	4.19e-05	0.0006	CcSEcCtD
Lamivudine—Shock—Triamcinolone—multiple sclerosis	4.16e-05	0.000596	CcSEcCtD
Lamivudine—Insomnia—Prednisolone—multiple sclerosis	4.16e-05	0.000596	CcSEcCtD
Lamivudine—Alopecia—Prednisone—multiple sclerosis	4.16e-05	0.000595	CcSEcCtD
Lamivudine—Shock—Methylprednisolone—multiple sclerosis	4.15e-05	0.000595	CcSEcCtD
Lamivudine—ABCB1—brain—multiple sclerosis	4.15e-05	0.0016	CbGeAlD
Lamivudine—Hepatobiliary disease—Methotrexate—multiple sclerosis	4.14e-05	0.000593	CcSEcCtD
Lamivudine—Nervous system disorder—Methylprednisolone—multiple sclerosis	4.14e-05	0.000593	CcSEcCtD
Lamivudine—Loss of consciousness—Betamethasone—multiple sclerosis	4.13e-05	0.000592	CcSEcCtD
Lamivudine—Loss of consciousness—Dexamethasone—multiple sclerosis	4.13e-05	0.000592	CcSEcCtD
Lamivudine—Epistaxis—Methotrexate—multiple sclerosis	4.13e-05	0.000592	CcSEcCtD
Lamivudine—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.13e-05	0.000592	CcSEcCtD
Lamivudine—Paraesthesia—Prednisolone—multiple sclerosis	4.13e-05	0.000591	CcSEcCtD
Lamivudine—Nausea—Azathioprine—multiple sclerosis	4.12e-05	0.00059	CcSEcCtD
Lamivudine—Skin disorder—Methylprednisolone—multiple sclerosis	4.1e-05	0.000587	CcSEcCtD
Lamivudine—Erythema—Prednisone—multiple sclerosis	4.1e-05	0.000586	CcSEcCtD
Lamivudine—Malnutrition—Prednisone—multiple sclerosis	4.1e-05	0.000586	CcSEcCtD
Lamivudine—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.09e-05	0.000586	CcSEcCtD
Lamivudine—Agranulocytosis—Methotrexate—multiple sclerosis	4.09e-05	0.000585	CcSEcCtD
Lamivudine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.08e-05	0.000584	CcSEcCtD
Lamivudine—Convulsion—Dexamethasone—multiple sclerosis	4.08e-05	0.000583	CcSEcCtD
Lamivudine—Convulsion—Betamethasone—multiple sclerosis	4.08e-05	0.000583	CcSEcCtD
Lamivudine—Asthenia—Mitoxantrone—multiple sclerosis	4.02e-05	0.000576	CcSEcCtD
Lamivudine—Myalgia—Betamethasone—multiple sclerosis	4.01e-05	0.000573	CcSEcCtD
Lamivudine—Myalgia—Dexamethasone—multiple sclerosis	4.01e-05	0.000573	CcSEcCtD
Lamivudine—Anxiety—Dexamethasone—multiple sclerosis	3.99e-05	0.000571	CcSEcCtD
Lamivudine—Anxiety—Betamethasone—multiple sclerosis	3.99e-05	0.000571	CcSEcCtD
Lamivudine—Discomfort—Dexamethasone—multiple sclerosis	3.96e-05	0.000566	CcSEcCtD
Lamivudine—Discomfort—Betamethasone—multiple sclerosis	3.96e-05	0.000566	CcSEcCtD
Lamivudine—Hypotension—Methylprednisolone—multiple sclerosis	3.95e-05	0.000565	CcSEcCtD
Lamivudine—Pain—Prednisolone—multiple sclerosis	3.93e-05	0.000563	CcSEcCtD
Lamivudine—Hepatitis—Methotrexate—multiple sclerosis	3.93e-05	0.000563	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—multiple sclerosis	3.9e-05	0.000559	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	3.86e-05	0.000552	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	3.85e-05	0.000551	CcSEcCtD
Lamivudine—Anaphylactic shock—Dexamethasone—multiple sclerosis	3.84e-05	0.00055	CcSEcCtD
Lamivudine—Oedema—Dexamethasone—multiple sclerosis	3.84e-05	0.00055	CcSEcCtD
Lamivudine—Anaphylactic shock—Betamethasone—multiple sclerosis	3.84e-05	0.00055	CcSEcCtD
Lamivudine—Oedema—Betamethasone—multiple sclerosis	3.84e-05	0.00055	CcSEcCtD
Lamivudine—Diarrhoea—Mitoxantrone—multiple sclerosis	3.84e-05	0.000549	CcSEcCtD
Lamivudine—Insomnia—Triamcinolone—multiple sclerosis	3.83e-05	0.000548	CcSEcCtD
Lamivudine—Insomnia—Methylprednisolone—multiple sclerosis	3.82e-05	0.000547	CcSEcCtD
Lamivudine—Infection—Betamethasone—multiple sclerosis	3.81e-05	0.000546	CcSEcCtD
Lamivudine—Infection—Dexamethasone—multiple sclerosis	3.81e-05	0.000546	CcSEcCtD
Lamivudine—Ill-defined disorder—Prednisone—multiple sclerosis	3.8e-05	0.000544	CcSEcCtD
Lamivudine—Paraesthesia—Triamcinolone—multiple sclerosis	3.8e-05	0.000544	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisolone—multiple sclerosis	3.79e-05	0.000543	CcSEcCtD
Lamivudine—Paraesthesia—Methylprednisolone—multiple sclerosis	3.79e-05	0.000543	CcSEcCtD
Lamivudine—Anaemia—Prednisone—multiple sclerosis	3.79e-05	0.000542	CcSEcCtD
Lamivudine—Shock—Dexamethasone—multiple sclerosis	3.78e-05	0.000541	CcSEcCtD
Lamivudine—Shock—Betamethasone—multiple sclerosis	3.78e-05	0.000541	CcSEcCtD
Lamivudine—Dyspnoea—Triamcinolone—multiple sclerosis	3.77e-05	0.00054	CcSEcCtD
Lamivudine—Nervous system disorder—Dexamethasone—multiple sclerosis	3.77e-05	0.000539	CcSEcCtD
Lamivudine—Nervous system disorder—Betamethasone—multiple sclerosis	3.77e-05	0.000539	CcSEcCtD
Lamivudine—Thrombocytopenia—Dexamethasone—multiple sclerosis	3.76e-05	0.000538	CcSEcCtD
Lamivudine—Thrombocytopenia—Betamethasone—multiple sclerosis	3.76e-05	0.000538	CcSEcCtD
Lamivudine—Angioedema—Prednisone—multiple sclerosis	3.74e-05	0.000536	CcSEcCtD
Lamivudine—Dyspepsia—Triamcinolone—multiple sclerosis	3.72e-05	0.000533	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—multiple sclerosis	3.72e-05	0.000532	CcSEcCtD
Lamivudine—Dyspepsia—Methylprednisolone—multiple sclerosis	3.72e-05	0.000532	CcSEcCtD
Lamivudine—Hyperhidrosis—Betamethasone—multiple sclerosis	3.71e-05	0.000531	CcSEcCtD
Lamivudine—Hyperhidrosis—Dexamethasone—multiple sclerosis	3.71e-05	0.000531	CcSEcCtD
Lamivudine—Malaise—Prednisone—multiple sclerosis	3.69e-05	0.000529	CcSEcCtD
Lamivudine—Vertigo—Prednisone—multiple sclerosis	3.68e-05	0.000527	CcSEcCtD
Lamivudine—Syncope—Prednisone—multiple sclerosis	3.67e-05	0.000526	CcSEcCtD
Lamivudine—Anorexia—Dexamethasone—multiple sclerosis	3.66e-05	0.000524	CcSEcCtD
Lamivudine—Anorexia—Betamethasone—multiple sclerosis	3.66e-05	0.000524	CcSEcCtD
Lamivudine—Urticaria—Prednisolone—multiple sclerosis	3.66e-05	0.000523	CcSEcCtD
Lamivudine—Fatigue—Triamcinolone—multiple sclerosis	3.65e-05	0.000522	CcSEcCtD
Lamivudine—Fatigue—Methylprednisolone—multiple sclerosis	3.64e-05	0.000521	CcSEcCtD
Lamivudine—Pain—Triamcinolone—multiple sclerosis	3.62e-05	0.000518	CcSEcCtD
Lamivudine—Loss of consciousness—Prednisone—multiple sclerosis	3.6e-05	0.000515	CcSEcCtD
Lamivudine—Hypotension—Dexamethasone—multiple sclerosis	3.59e-05	0.000514	CcSEcCtD
Lamivudine—Hypotension—Betamethasone—multiple sclerosis	3.59e-05	0.000514	CcSEcCtD
Lamivudine—Vomiting—Mitoxantrone—multiple sclerosis	3.57e-05	0.00051	CcSEcCtD
Lamivudine—Immune system disorder—Methotrexate—multiple sclerosis	3.55e-05	0.000509	CcSEcCtD
Lamivudine—Convulsion—Prednisone—multiple sclerosis	3.55e-05	0.000508	CcSEcCtD
Lamivudine—Mediastinal disorder—Methotrexate—multiple sclerosis	3.54e-05	0.000507	CcSEcCtD
Lamivudine—Rash—Mitoxantrone—multiple sclerosis	3.54e-05	0.000506	CcSEcCtD
Lamivudine—Dermatitis—Mitoxantrone—multiple sclerosis	3.53e-05	0.000506	CcSEcCtD
Lamivudine—Chills—Methotrexate—multiple sclerosis	3.53e-05	0.000505	CcSEcCtD
Lamivudine—Headache—Mitoxantrone—multiple sclerosis	3.51e-05	0.000503	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.5e-05	0.000501	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.5e-05	0.000501	CcSEcCtD
Lamivudine—Myalgia—Prednisone—multiple sclerosis	3.49e-05	0.000499	CcSEcCtD
Lamivudine—Arthralgia—Prednisone—multiple sclerosis	3.49e-05	0.000499	CcSEcCtD
Lamivudine—Feeling abnormal—Triamcinolone—multiple sclerosis	3.49e-05	0.000499	CcSEcCtD
Lamivudine—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.48e-05	0.000498	CcSEcCtD
Lamivudine—Anxiety—Prednisone—multiple sclerosis	3.48e-05	0.000498	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—multiple sclerosis	3.48e-05	0.000498	CcSEcCtD
Lamivudine—Insomnia—Betamethasone—multiple sclerosis	3.47e-05	0.000497	CcSEcCtD
Lamivudine—Insomnia—Dexamethasone—multiple sclerosis	3.47e-05	0.000497	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.46e-05	0.000496	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.45e-05	0.000494	CcSEcCtD
Lamivudine—Paraesthesia—Dexamethasone—multiple sclerosis	3.45e-05	0.000494	CcSEcCtD
Lamivudine—Paraesthesia—Betamethasone—multiple sclerosis	3.45e-05	0.000494	CcSEcCtD
Lamivudine—Discomfort—Prednisone—multiple sclerosis	3.45e-05	0.000493	CcSEcCtD
Lamivudine—Erythema—Methotrexate—multiple sclerosis	3.42e-05	0.00049	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—multiple sclerosis	3.42e-05	0.00049	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisolone—multiple sclerosis	3.39e-05	0.000485	CcSEcCtD
Lamivudine—Dyspepsia—Dexamethasone—multiple sclerosis	3.38e-05	0.000484	CcSEcCtD
Lamivudine—Dyspepsia—Betamethasone—multiple sclerosis	3.38e-05	0.000484	CcSEcCtD
Lamivudine—Urticaria—Triamcinolone—multiple sclerosis	3.36e-05	0.000481	CcSEcCtD
Lamivudine—Urticaria—Methylprednisolone—multiple sclerosis	3.35e-05	0.00048	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—multiple sclerosis	3.35e-05	0.00048	CcSEcCtD
Lamivudine—Body temperature increased—Triamcinolone—multiple sclerosis	3.35e-05	0.000479	CcSEcCtD
Lamivudine—Oedema—Prednisone—multiple sclerosis	3.34e-05	0.000479	CcSEcCtD
Lamivudine—Anaphylactic shock—Prednisone—multiple sclerosis	3.34e-05	0.000479	CcSEcCtD
Lamivudine—Abdominal pain—Methylprednisolone—multiple sclerosis	3.34e-05	0.000478	CcSEcCtD
Lamivudine—Decreased appetite—Dexamethasone—multiple sclerosis	3.34e-05	0.000478	CcSEcCtD
Lamivudine—Decreased appetite—Betamethasone—multiple sclerosis	3.34e-05	0.000478	CcSEcCtD
Lamivudine—Nausea—Mitoxantrone—multiple sclerosis	3.33e-05	0.000477	CcSEcCtD
Lamivudine—Infection—Prednisone—multiple sclerosis	3.32e-05	0.000476	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.31e-05	0.000475	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.31e-05	0.000475	CcSEcCtD
Lamivudine—Back pain—Methotrexate—multiple sclerosis	3.31e-05	0.000474	CcSEcCtD
Lamivudine—Fatigue—Dexamethasone—multiple sclerosis	3.31e-05	0.000474	CcSEcCtD
Lamivudine—Fatigue—Betamethasone—multiple sclerosis	3.31e-05	0.000474	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.31e-05	0.001	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.29e-05	0.000997	CbGpPWpGaD
Lamivudine—Shock—Prednisone—multiple sclerosis	3.29e-05	0.000471	CcSEcCtD
Lamivudine—Pain—Betamethasone—multiple sclerosis	3.28e-05	0.00047	CcSEcCtD
Lamivudine—Pain—Dexamethasone—multiple sclerosis	3.28e-05	0.00047	CcSEcCtD
Lamivudine—Nervous system disorder—Prednisone—multiple sclerosis	3.28e-05	0.000469	CcSEcCtD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.25e-05	0.000985	CbGpPWpGaD
Lamivudine—Skin disorder—Prednisone—multiple sclerosis	3.25e-05	0.000465	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—multiple sclerosis	3.23e-05	0.000463	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	3.19e-05	0.000968	CbGpPWpGaD
Lamivudine—Anorexia—Prednisone—multiple sclerosis	3.19e-05	0.000456	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.18e-05	0.000963	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.18e-05	0.000963	CbGpPWpGaD
Lamivudine—Ill-defined disorder—Methotrexate—multiple sclerosis	3.18e-05	0.000455	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.17e-05	0.000962	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	3.17e-05	0.00096	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.17e-05	0.000959	CbGpPWpGaD
Lamivudine—Anaemia—Methotrexate—multiple sclerosis	3.16e-05	0.000453	CcSEcCtD
Lamivudine—Feeling abnormal—Betamethasone—multiple sclerosis	3.16e-05	0.000453	CcSEcCtD
Lamivudine—Feeling abnormal—Dexamethasone—multiple sclerosis	3.16e-05	0.000453	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.14e-05	0.000953	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.14e-05	0.000449	CcSEcCtD
Lamivudine—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.14e-05	0.000449	CcSEcCtD
Lamivudine—Hypersensitivity—Triamcinolone—multiple sclerosis	3.12e-05	0.000446	CcSEcCtD
Lamivudine—DCK—Metabolism—CYP27B1—multiple sclerosis	3.11e-05	0.000943	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP24A1—multiple sclerosis	3.11e-05	0.000943	CbGpPWpGaD
Lamivudine—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.11e-05	0.000445	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.1e-05	0.000941	CbGpPWpGaD
Lamivudine—Malaise—Methotrexate—multiple sclerosis	3.09e-05	0.000442	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—multiple sclerosis	3.08e-05	0.00044	CcSEcCtD
Lamivudine—PGK1—Metabolism—BCHE—multiple sclerosis	3.07e-05	0.000929	CbGpPWpGaD
Lamivudine—Leukopenia—Methotrexate—multiple sclerosis	3.06e-05	0.000439	CcSEcCtD
Lamivudine—Urticaria—Dexamethasone—multiple sclerosis	3.05e-05	0.000437	CcSEcCtD
Lamivudine—Urticaria—Betamethasone—multiple sclerosis	3.05e-05	0.000437	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	3.05e-05	0.000924	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.05e-05	0.000436	CcSEcCtD
Lamivudine—Dizziness—Prednisolone—multiple sclerosis	3.04e-05	0.000436	CcSEcCtD
Lamivudine—Asthenia—Triamcinolone—multiple sclerosis	3.04e-05	0.000435	CcSEcCtD
Lamivudine—Body temperature increased—Betamethasone—multiple sclerosis	3.04e-05	0.000434	CcSEcCtD
Lamivudine—Abdominal pain—Dexamethasone—multiple sclerosis	3.04e-05	0.000434	CcSEcCtD
Lamivudine—Body temperature increased—Dexamethasone—multiple sclerosis	3.04e-05	0.000434	CcSEcCtD
Lamivudine—Abdominal pain—Betamethasone—multiple sclerosis	3.04e-05	0.000434	CcSEcCtD
Lamivudine—Asthenia—Methylprednisolone—multiple sclerosis	3.03e-05	0.000434	CcSEcCtD
Lamivudine—Insomnia—Prednisone—multiple sclerosis	3.02e-05	0.000433	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.02e-05	0.000914	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	3e-05	0.00091	CbGpPWpGaD
Lamivudine—Paraesthesia—Prednisone—multiple sclerosis	3e-05	0.00043	CcSEcCtD
Lamivudine—Pruritus—Triamcinolone—multiple sclerosis	2.99e-05	0.000429	CcSEcCtD
Lamivudine—Cough—Methotrexate—multiple sclerosis	2.99e-05	0.000428	CcSEcCtD
Lamivudine—Pruritus—Methylprednisolone—multiple sclerosis	2.99e-05	0.000428	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—multiple sclerosis	2.97e-05	0.000425	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.96e-05	0.000896	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.96e-05	0.000896	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.95e-05	0.000894	CbGpPWpGaD
Lamivudine—Dyspepsia—Prednisone—multiple sclerosis	2.94e-05	0.000421	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—multiple sclerosis	2.91e-05	0.000417	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—multiple sclerosis	2.91e-05	0.000417	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—multiple sclerosis	2.91e-05	0.000417	CcSEcCtD
Lamivudine—Decreased appetite—Prednisone—multiple sclerosis	2.91e-05	0.000416	CcSEcCtD
Lamivudine—Rash—Prednisolone—multiple sclerosis	2.9e-05	0.000415	CcSEcCtD
Lamivudine—Dermatitis—Prednisolone—multiple sclerosis	2.9e-05	0.000415	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.89e-05	0.000414	CcSEcCtD
Lamivudine—Diarrhoea—Methylprednisolone—multiple sclerosis	2.89e-05	0.000414	CcSEcCtD
Lamivudine—Fatigue—Prednisone—multiple sclerosis	2.88e-05	0.000413	CcSEcCtD
Lamivudine—Headache—Prednisolone—multiple sclerosis	2.88e-05	0.000413	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—multiple sclerosis	2.88e-05	0.000412	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.86e-05	0.000867	CbGpPWpGaD
Lamivudine—Constipation—Prednisone—multiple sclerosis	2.86e-05	0.000409	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—BCHE—multiple sclerosis	2.85e-05	0.000864	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GPC5—multiple sclerosis	2.85e-05	0.000863	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.83e-05	0.000858	CbGpPWpGaD
Lamivudine—Confusional state—Methotrexate—multiple sclerosis	2.82e-05	0.000403	CcSEcCtD
Lamivudine—Dizziness—Triamcinolone—multiple sclerosis	2.8e-05	0.000401	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—multiple sclerosis	2.79e-05	0.0004	CcSEcCtD
Lamivudine—Dizziness—Methylprednisolone—multiple sclerosis	2.79e-05	0.0004	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—SRM—multiple sclerosis	2.79e-05	0.000846	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.78e-05	0.000843	CbGpPWpGaD
Lamivudine—Infection—Methotrexate—multiple sclerosis	2.78e-05	0.000397	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisone—multiple sclerosis	2.76e-05	0.000394	CcSEcCtD
Lamivudine—Asthenia—Dexamethasone—multiple sclerosis	2.75e-05	0.000394	CcSEcCtD
Lamivudine—Asthenia—Betamethasone—multiple sclerosis	2.75e-05	0.000394	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.75e-05	0.000834	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	2.74e-05	0.000832	CbGpPWpGaD
Lamivudine—Nervous system disorder—Methotrexate—multiple sclerosis	2.74e-05	0.000392	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—multiple sclerosis	2.74e-05	0.000392	CcSEcCtD
Lamivudine—Gastrointestinal pain—Prednisone—multiple sclerosis	2.73e-05	0.000391	CcSEcCtD
Lamivudine—Nausea—Prednisolone—multiple sclerosis	2.73e-05	0.000391	CcSEcCtD
Lamivudine—PGK1—Disease—CD86—multiple sclerosis	2.73e-05	0.000827	CbGpPWpGaD
Lamivudine—Pruritus—Betamethasone—multiple sclerosis	2.72e-05	0.000389	CcSEcCtD
Lamivudine—Pruritus—Dexamethasone—multiple sclerosis	2.72e-05	0.000389	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—multiple sclerosis	2.71e-05	0.000389	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.7e-05	0.00082	CbGpPWpGaD
Lamivudine—Hyperhidrosis—Methotrexate—multiple sclerosis	2.7e-05	0.000387	CcSEcCtD
Lamivudine—Vomiting—Triamcinolone—multiple sclerosis	2.69e-05	0.000385	CcSEcCtD
Lamivudine—Vomiting—Methylprednisolone—multiple sclerosis	2.68e-05	0.000384	CcSEcCtD
Lamivudine—Rash—Triamcinolone—multiple sclerosis	2.67e-05	0.000382	CcSEcCtD
Lamivudine—Dermatitis—Triamcinolone—multiple sclerosis	2.67e-05	0.000382	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—multiple sclerosis	2.66e-05	0.000381	CcSEcCtD
Lamivudine—Rash—Methylprednisolone—multiple sclerosis	2.66e-05	0.000381	CcSEcCtD
Lamivudine—Dermatitis—Methylprednisolone—multiple sclerosis	2.66e-05	0.000381	CcSEcCtD
Lamivudine—Urticaria—Prednisone—multiple sclerosis	2.66e-05	0.00038	CcSEcCtD
Lamivudine—Headache—Triamcinolone—multiple sclerosis	2.65e-05	0.000379	CcSEcCtD
Lamivudine—Headache—Methylprednisolone—multiple sclerosis	2.64e-05	0.000379	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	2.64e-05	0.000801	CbGpPWpGaD
Lamivudine—Body temperature increased—Prednisone—multiple sclerosis	2.64e-05	0.000378	CcSEcCtD
Lamivudine—Abdominal pain—Prednisone—multiple sclerosis	2.64e-05	0.000378	CcSEcCtD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.64e-05	0.0008	CbGpPWpGaD
Lamivudine—Diarrhoea—Dexamethasone—multiple sclerosis	2.63e-05	0.000376	CcSEcCtD
Lamivudine—Diarrhoea—Betamethasone—multiple sclerosis	2.63e-05	0.000376	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—multiple sclerosis	2.61e-05	0.000374	CcSEcCtD
Lamivudine—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	2.61e-05	0.00079	CbGpPWpGaD
Lamivudine—NME2—Metabolism—BCHE—multiple sclerosis	2.61e-05	0.00079	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.59e-05	0.000786	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.59e-05	0.000784	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.57e-05	0.00078	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SRM—multiple sclerosis	2.56e-05	0.000777	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.55e-05	0.000364	CcSEcCtD
Lamivudine—Dizziness—Betamethasone—multiple sclerosis	2.54e-05	0.000363	CcSEcCtD
Lamivudine—Dizziness—Dexamethasone—multiple sclerosis	2.54e-05	0.000363	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—multiple sclerosis	2.53e-05	0.000362	CcSEcCtD
Lamivudine—Nausea—Triamcinolone—multiple sclerosis	2.51e-05	0.00036	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—multiple sclerosis	2.51e-05	0.000359	CcSEcCtD
Lamivudine—Nausea—Methylprednisolone—multiple sclerosis	2.51e-05	0.000359	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.49e-05	0.000756	CbGpPWpGaD
Lamivudine—Dyspnoea—Methotrexate—multiple sclerosis	2.49e-05	0.000357	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.49e-05	0.000753	CbGpPWpGaD
Lamivudine—Somnolence—Methotrexate—multiple sclerosis	2.48e-05	0.000356	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	2.47e-05	0.00075	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.46e-05	0.000747	CbGpPWpGaD
Lamivudine—Hypersensitivity—Prednisone—multiple sclerosis	2.46e-05	0.000353	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—multiple sclerosis	2.46e-05	0.000352	CcSEcCtD
Lamivudine—Vomiting—Dexamethasone—multiple sclerosis	2.44e-05	0.000349	CcSEcCtD
Lamivudine—Vomiting—Betamethasone—multiple sclerosis	2.44e-05	0.000349	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—multiple sclerosis	2.43e-05	0.000348	CcSEcCtD
Lamivudine—Rash—Betamethasone—multiple sclerosis	2.42e-05	0.000347	CcSEcCtD
Lamivudine—Rash—Dexamethasone—multiple sclerosis	2.42e-05	0.000347	CcSEcCtD
Lamivudine—PGK1—Disease—CCR5—multiple sclerosis	2.42e-05	0.000734	CbGpPWpGaD
Lamivudine—Dermatitis—Dexamethasone—multiple sclerosis	2.42e-05	0.000346	CcSEcCtD
Lamivudine—Dermatitis—Betamethasone—multiple sclerosis	2.42e-05	0.000346	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.41e-05	0.000345	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—multiple sclerosis	2.41e-05	0.000345	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—SELE—multiple sclerosis	2.41e-05	0.000729	CbGpPWpGaD
Lamivudine—Headache—Betamethasone—multiple sclerosis	2.41e-05	0.000344	CcSEcCtD
Lamivudine—Headache—Dexamethasone—multiple sclerosis	2.41e-05	0.000344	CcSEcCtD
Lamivudine—Asthenia—Prednisone—multiple sclerosis	2.4e-05	0.000343	CcSEcCtD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.39e-05	0.000725	CbGpPWpGaD
Lamivudine—Pain—Methotrexate—multiple sclerosis	2.39e-05	0.000342	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	2.38e-05	0.000722	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	2.38e-05	0.00072	CbGpPWpGaD
Lamivudine—Pruritus—Prednisone—multiple sclerosis	2.37e-05	0.000339	CcSEcCtD
Lamivudine—DCK—Metabolism—RRM1—multiple sclerosis	2.36e-05	0.000715	CbGpPWpGaD
Lamivudine—PGK1—Disease—HLA-A—multiple sclerosis	2.36e-05	0.000715	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.34e-05	0.000708	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	2.34e-05	0.000708	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	2.34e-05	0.000708	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.31e-05	0.000699	CbGpPWpGaD
Lamivudine—Feeling abnormal—Methotrexate—multiple sclerosis	2.3e-05	0.00033	CcSEcCtD
Lamivudine—Diarrhoea—Prednisone—multiple sclerosis	2.29e-05	0.000327	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.29e-05	0.000327	CcSEcCtD
Lamivudine—Nausea—Dexamethasone—multiple sclerosis	2.28e-05	0.000326	CcSEcCtD
Lamivudine—Nausea—Betamethasone—multiple sclerosis	2.28e-05	0.000326	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	2.27e-05	0.000689	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.26e-05	0.000686	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—APOE—multiple sclerosis	2.26e-05	0.000686	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—APOE—multiple sclerosis	2.26e-05	0.000686	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—APOE—multiple sclerosis	2.26e-05	0.000686	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	2.22e-05	0.000673	CbGpPWpGaD
Lamivudine—Urticaria—Methotrexate—multiple sclerosis	2.22e-05	0.000318	CcSEcCtD
Lamivudine—Dizziness—Prednisone—multiple sclerosis	2.21e-05	0.000317	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—multiple sclerosis	2.21e-05	0.000316	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—multiple sclerosis	2.21e-05	0.000316	CcSEcCtD
Lamivudine—PGK1—Disease—APOE—multiple sclerosis	2.2e-05	0.000667	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.2e-05	0.000666	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.17e-05	0.000657	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.15e-05	0.00065	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—BCHE—multiple sclerosis	2.13e-05	0.000646	CbGpPWpGaD
Lamivudine—Vomiting—Prednisone—multiple sclerosis	2.13e-05	0.000304	CcSEcCtD
Lamivudine—Rash—Prednisone—multiple sclerosis	2.11e-05	0.000302	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—multiple sclerosis	2.11e-05	0.000302	CcSEcCtD
Lamivudine—Headache—Prednisone—multiple sclerosis	2.09e-05	0.0003	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.09e-05	0.000635	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.08e-05	0.000631	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.07e-05	0.000626	CbGpPWpGaD
Lamivudine—Hypersensitivity—Methotrexate—multiple sclerosis	2.06e-05	0.000295	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.06e-05	0.000624	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.03e-05	0.000617	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SRM—multiple sclerosis	2.01e-05	0.000609	CbGpPWpGaD
Lamivudine—Asthenia—Methotrexate—multiple sclerosis	2e-05	0.000287	CcSEcCtD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2e-05	0.000606	CbGpPWpGaD
Lamivudine—PGK1—Disease—CD80—multiple sclerosis	1.99e-05	0.000603	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—BCHE—multiple sclerosis	1.99e-05	0.000602	CbGpPWpGaD
Lamivudine—Nausea—Prednisone—multiple sclerosis	1.99e-05	0.000284	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—multiple sclerosis	1.98e-05	0.000283	CcSEcCtD
Lamivudine—NME1—Metabolism—BCHE—multiple sclerosis	1.98e-05	0.000599	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.97e-05	0.000597	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP27B1—multiple sclerosis	1.97e-05	0.000596	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP24A1—multiple sclerosis	1.97e-05	0.000596	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.95e-05	0.00059	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—POMC—multiple sclerosis	1.94e-05	0.000589	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—POMC—multiple sclerosis	1.94e-05	0.000589	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—POMC—multiple sclerosis	1.94e-05	0.000589	CbGpPWpGaD
Lamivudine—Diarrhoea—Methotrexate—multiple sclerosis	1.91e-05	0.000274	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.88e-05	0.00057	CbGpPWpGaD
Lamivudine—Dizziness—Methotrexate—multiple sclerosis	1.85e-05	0.000265	CcSEcCtD
Lamivudine—PGK1—Metabolism—APOE—multiple sclerosis	1.84e-05	0.000559	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP27B1—multiple sclerosis	1.81e-05	0.000548	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP24A1—multiple sclerosis	1.81e-05	0.000548	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.8e-05	0.000545	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPC5—multiple sclerosis	1.8e-05	0.000545	CbGpPWpGaD
Lamivudine—Vomiting—Methotrexate—multiple sclerosis	1.78e-05	0.000254	CcSEcCtD
Lamivudine—PCYT2—Metabolism—ALB—multiple sclerosis	1.77e-05	0.000537	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ALB—multiple sclerosis	1.77e-05	0.000537	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ALB—multiple sclerosis	1.77e-05	0.000537	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SRM—multiple sclerosis	1.77e-05	0.000536	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.77e-05	0.000535	CbGpPWpGaD
Lamivudine—Rash—Methotrexate—multiple sclerosis	1.76e-05	0.000252	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—multiple sclerosis	1.76e-05	0.000252	CcSEcCtD
Lamivudine—Headache—Methotrexate—multiple sclerosis	1.75e-05	0.000251	CcSEcCtD
Lamivudine—SLC22A2—Metabolism—SRM—multiple sclerosis	1.75e-05	0.00053	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.74e-05	0.000528	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ITGA4—multiple sclerosis	1.74e-05	0.000527	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.74e-05	0.000527	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IFNB1—multiple sclerosis	1.73e-05	0.000523	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.72e-05	0.000522	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—APOE—multiple sclerosis	1.71e-05	0.00052	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.71e-05	0.000519	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.7e-05	0.000514	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.69e-05	0.000513	CbGpPWpGaD
Lamivudine—PGK1—Disease—TYK2—multiple sclerosis	1.68e-05	0.000509	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.67e-05	0.000505	CbGpPWpGaD
Lamivudine—Nausea—Methotrexate—multiple sclerosis	1.66e-05	0.000238	CcSEcCtD
Lamivudine—ABCC3—Metabolism—GPC5—multiple sclerosis	1.65e-05	0.000501	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SRM—multiple sclerosis	1.63e-05	0.000494	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—POMC—multiple sclerosis	1.58e-05	0.00048	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.58e-05	0.000479	CbGpPWpGaD
Lamivudine—NME2—Metabolism—APOE—multiple sclerosis	1.57e-05	0.000475	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	1.56e-05	0.000474	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.55e-05	0.000469	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GPC5—multiple sclerosis	1.55e-05	0.000469	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	1.54e-05	0.000467	CbGpPWpGaD
Lamivudine—PGK1—Disease—CD4—multiple sclerosis	1.52e-05	0.000461	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.51e-05	0.000459	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.5e-05	0.000456	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.5e-05	0.000454	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—RRM1—multiple sclerosis	1.49e-05	0.000452	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—POMC—multiple sclerosis	1.47e-05	0.000446	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	1.47e-05	0.000445	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ALB—multiple sclerosis	1.44e-05	0.000438	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	0.000429	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	0.000429	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.4e-05	0.000424	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.4e-05	0.000424	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.38e-05	0.000419	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.37e-05	0.000416	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—RRM1—multiple sclerosis	1.37e-05	0.000415	CbGpPWpGaD
Lamivudine—DCK—Metabolism—BCHE—multiple sclerosis	1.35e-05	0.000411	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.35e-05	0.00041	CbGpPWpGaD
Lamivudine—NME2—Metabolism—POMC—multiple sclerosis	1.35e-05	0.000408	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ALB—multiple sclerosis	1.34e-05	0.000407	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.000392	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.27e-05	0.000386	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.25e-05	0.000378	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.25e-05	0.000378	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.24e-05	0.000375	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	1.23e-05	0.000374	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	1.23e-05	0.000374	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ALB—multiple sclerosis	1.23e-05	0.000372	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.23e-05	0.000371	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.22e-05	0.00037	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.21e-05	0.000366	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2RA—multiple sclerosis	1.19e-05	0.00036	CbGpPWpGaD
Lamivudine—NME1—Metabolism—APOE—multiple sclerosis	1.19e-05	0.00036	CbGpPWpGaD
Lamivudine—PGK1—Disease—STAT3—multiple sclerosis	1.18e-05	0.000357	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.17e-05	0.000355	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	1.15e-05	0.000348	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	1.15e-05	0.000348	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPC5—multiple sclerosis	1.14e-05	0.000345	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPC5—multiple sclerosis	1.13e-05	0.000342	CbGpPWpGaD
Lamivudine—PGK1—Disease—MYC—multiple sclerosis	1.09e-05	0.000331	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—multiple sclerosis	1.09e-05	0.000331	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—RRM1—multiple sclerosis	1.07e-05	0.000325	CbGpPWpGaD
Lamivudine—PGK1—Disease—MAPK1—multiple sclerosis	1.07e-05	0.000324	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.06e-05	0.000322	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.06e-05	0.000322	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.05e-05	0.00032	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPC5—multiple sclerosis	1.05e-05	0.000319	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.03e-05	0.000313	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.03e-05	0.000313	CbGpPWpGaD
Lamivudine—NME1—Metabolism—POMC—multiple sclerosis	1.02e-05	0.000309	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RPL5—multiple sclerosis	1.01e-05	0.000305	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.9e-06	0.0003	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC11A1—multiple sclerosis	9.63e-06	0.000292	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SRM—multiple sclerosis	9.56e-06	0.00029	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	9.52e-06	0.000289	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RRM1—multiple sclerosis	9.44e-06	0.000286	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RRM1—multiple sclerosis	9.34e-06	0.000283	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ALB—multiple sclerosis	9.31e-06	0.000282	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.27e-06	0.000281	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.13e-06	0.000277	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	8.89e-06	0.000269	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RRM1—multiple sclerosis	8.71e-06	0.000264	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.61e-06	0.000261	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—multiple sclerosis	8.59e-06	0.00026	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BCHE—multiple sclerosis	8.56e-06	0.000259	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.32e-06	0.000252	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.32e-06	0.000252	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—multiple sclerosis	8.22e-06	0.000249	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.19e-06	0.000248	CbGpPWpGaD
Lamivudine—DCK—Metabolism—APOE—multiple sclerosis	8.15e-06	0.000247	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.13e-06	0.000246	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.91e-06	0.00024	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BCHE—multiple sclerosis	7.86e-06	0.000238	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD28—multiple sclerosis	7.69e-06	0.000233	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.58e-06	0.00023	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.44e-06	0.000225	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.15e-06	0.000217	CbGpPWpGaD
Lamivudine—DCK—Metabolism—POMC—multiple sclerosis	7e-06	0.000212	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—multiple sclerosis	6.97e-06	0.000211	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	6.73e-06	0.000204	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	6.73e-06	0.000204	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.52e-06	0.000198	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.47e-06	0.000196	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—multiple sclerosis	6.38e-06	0.000193	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.27e-06	0.00019	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	6.23e-06	0.000189	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.2e-06	0.000188	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BCHE—multiple sclerosis	6.16e-06	0.000187	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPC5—multiple sclerosis	6.16e-06	0.000187	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	5.8e-06	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD86—multiple sclerosis	5.49e-06	0.000166	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.45e-06	0.000165	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—multiple sclerosis	5.43e-06	0.000165	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BCHE—multiple sclerosis	5.42e-06	0.000164	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.4e-06	0.000164	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BCHE—multiple sclerosis	5.37e-06	0.000163	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK1—multiple sclerosis	5.33e-06	0.000162	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—multiple sclerosis	5.15e-06	0.000156	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RRM1—multiple sclerosis	5.1e-06	0.000155	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.03e-06	0.000153	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BCHE—multiple sclerosis	5e-06	0.000152	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CCR5—multiple sclerosis	4.87e-06	0.000147	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HLA-A—multiple sclerosis	4.74e-06	0.000144	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—multiple sclerosis	4.73e-06	0.000143	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.71e-06	0.000143	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.7e-06	0.000142	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.61e-06	0.00014	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—multiple sclerosis	4.43e-06	0.000134	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POMC—multiple sclerosis	4.42e-06	0.000134	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.39e-06	0.000133	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POMC—multiple sclerosis	4.06e-06	0.000123	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—multiple sclerosis	4.03e-06	0.000122	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD80—multiple sclerosis	4e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—multiple sclerosis	3.71e-06	0.000112	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—multiple sclerosis	3.71e-06	0.000112	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TYK2—multiple sclerosis	3.38e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—multiple sclerosis	3.26e-06	9.89e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—multiple sclerosis	3.23e-06	9.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POMC—multiple sclerosis	3.18e-06	9.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—multiple sclerosis	3.06e-06	9.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—multiple sclerosis	3.01e-06	9.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.95e-06	8.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—multiple sclerosis	2.93e-06	8.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—multiple sclerosis	2.9e-06	8.8e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POMC—multiple sclerosis	2.8e-06	8.49e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POMC—multiple sclerosis	2.77e-06	8.41e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POMC—multiple sclerosis	2.58e-06	7.83e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—multiple sclerosis	2.55e-06	7.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—multiple sclerosis	2.53e-06	7.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—multiple sclerosis	2.37e-06	7.17e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—multiple sclerosis	2.36e-06	7.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—multiple sclerosis	2.2e-06	6.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—multiple sclerosis	2.19e-06	6.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK1—multiple sclerosis	2.15e-06	6.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—multiple sclerosis	1.76e-06	5.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—multiple sclerosis	1.65e-06	5.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POMC—multiple sclerosis	1.51e-06	4.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—multiple sclerosis	1.38e-06	4.19e-05	CbGpPWpGaD
